首页 | 本学科首页   官方微博 | 高级检索  
     

经皮微创消融联合脾切除术序贯治疗小肝癌合并重度门静脉高压脾功能亢进(11例临床报告)
引用本文:沈强,钱国军,王能,吴胜沛. 经皮微创消融联合脾切除术序贯治疗小肝癌合并重度门静脉高压脾功能亢进(11例临床报告)[J]. 当代医学, 2009, 15(11): 178-179
作者姓名:沈强  钱国军  王能  吴胜沛
作者单位:上海,200438,第二军医大学附属东方肝胆外科医院超声介入科
摘    要:目的评估经皮微创消融联合脾切除术序贯治疗合并重度门静脉高压脾功能亢进的小肝癌的疗效和安全性。方法从2006年6月~2008年6月,我科收治的11例小肝癌合并门脉高压,脾功能亢进。我们先行脾切除术,术后恢复11天~4月后行PRFA或PMCT术治疗,术后随访肝功能、血常规、CT或MRI、AFP等。结果除1例脾切除术后出现胰漏,继发感染,给予抗生素冲洗、置管引流后恢复,于4月后行PMCT术,所有患者行微创消融无严重并发症,术后3~5天出院。结论对于重度肝硬化、门脉高压合并脾功能亢进的小肝癌病人,先行脾切除和(或)门奇静脉断流术,血小板及PT等指标改善后行经皮肝穿刺微创治疗是一种安全可行的治疗方法。

关 键 词:小肝癌  微创治疗  脾功能亢进  脾切除术

Sequential therapy of percutaneous microtraumatic ablation and splenectomy for small liver cancer with severe portal hypertension and hypersplenism(a report of 11 cases)
SHEN Qiang,QIAN Guo-jun,WANG Neng,WU Sheng-pei. Sequential therapy of percutaneous microtraumatic ablation and splenectomy for small liver cancer with severe portal hypertension and hypersplenism(a report of 11 cases)[J]. Contemporary Medicine, 2009, 15(11): 178-179
Authors:SHEN Qiang  QIAN Guo-jun  WANG Neng  WU Sheng-pei
Affiliation:SHEN Qiang,QIAN Guo-jun,WANG Neng,WU Sheng-pei Shanghai eastern hepatobiliary surgery hospital 200438 China
Abstract:objective To evaluate effect and safety of the Sequential therapy of percutaneous microtrauma ablation with splenectomy for small liver cancer with severe portal hypertension and hepersplenism. Methods: From June 2006 to June 2008, we adopted 11 patients who had small liver cancer with portal hypertension and hypersplenism. We operated splenectomy first, and then did PRFA or PMCT. And then we tested the liver function blood routine CT scan or MRI scan and so on. Results: One patient occurred postoperative p...
Keywords:small liver cancer  microinvasive therapy  hypersplenism  splenectomy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号